Pharmaceutical Intermediates Market Key Players and Forecast by 2028

Historic Data: 2018-2019 | Base Year: 2020 | Forecast Period: 2021-2028

Pharmaceutical Intermediates Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (GMP, and Non GMP); Applications (Antibiotics, Antipyretic Analgesics, Vitamins, and Others); Distribution Channel (Distributor, and Direct Sales), and Geography

Report Date : May 2021
Report Code : TIPRE00005559

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 185

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The pharmaceutical intermediates market is expected to reach US$ 37,290.33 million in 2028 from US$ 27,356.70 million in 2020. The market is estimated to grow with a CAGR of 4.2% from 2021-2028.

The pharmaceutical intermediates market has been analyzed on the basis of type, application, distribution channel, and region. The market based on region is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report emphasizes on parameters such as market trends, technological advancements, market dynamics, and leading company’s competitive landscape analysis to offers insights and in-depth analysis of the pharmaceutical intermediates market. It also includes the analysis of COVID-19 pandemic across the market in all the key regions.

Customize This Report To Suit Your Requirement
You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Pharmaceutical Intermediates Market: Strategic Insights

Get Top Key Market Trends of this report.
This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Market Insights

Rising Prevalence of Chronic Diseases and Infectious Diseases

Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the US suffer from at least one chronic disease such as cancer, heart disease, lung disease, stroke, neurological disease, diabetes, and kidney diseases. Moreover, 4 in 10 adults in the country have two or more chronic diseases. Additionally, according to the press release by the European Chronic Disease Alliance (ECDA), in 2014, 9 out of 10 people in Europe die due to chronic diseases. Thus, 70–80% of the total healthcare costs are spent on the management of chronic diseases.

The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. For instance, as per the Revised National Tuberculosis Control Programme Report, around 4.4 lakh patients died due to tuberculosis in India in 2018, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.

Type-Based Insights

The pharmaceutical intermediates market, by type, is segmented into GMP, and non GMP. The GMP segment held the largest share of the market in 2020, whereas the same segment is anticipated to register the highest CAGR of 4.4% in the market during the forecast period.

Application-Based Insights

The pharmaceutical intermediates market, by application, is segmented antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, also, this segment is anticipated to register the highest CAGR of 4.9% in the market during the forecast period.

Distribution Channel-Based Insights

On the basis of distribution channel, the pharmaceutical intermediates market has been segmented into distributor, and direct sales. The direct sales segment held the largest share of the market in 2020, and distributor segment is estimated to register the highest CAGR of 4.2% in the market during the forecast period.

Companies operating in the pharmaceutical intermediates market are adopting organic strategies such as product launches and expansions to expand their footprint and product portfolio worldwide as well as to address the growing demands.

Pharmaceutical Intermediates Market Regional Insights

The regional trends and factors influencing the Pharmaceutical Intermediates Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Pharmaceutical Intermediates Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

pharmaceutical-intermediates-market-global-geography

Get the Regional Specific Data for Pharmaceutical Intermediates Market

Pharmaceutical Intermediates Market Report Scope

Report Attribute	Details
Market size in 2020	US$ 27.36 Billion
Market Size by 2028	US$ 37.29 Billion
Global CAGR (2020 - 2028)	4.2%
Historical Data	2018-2019
Forecast period	2021-2028
Segments Covered	By Type GMP Non GMP By Applications Antibiotics Antipyretic Analgesics Vitamins By Distribution Channel Distributor Direct Sales
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Pfizer Inc. Sanofi BASF SE Lianhe Chemical Technology Co., Ltd Dishman Carbogen Amcis Ltd Codexis Midas Pharma GmbH chiracon GmbH Dextra Laboratories Limited

Pharmaceutical Intermediates Market Players Density: Understanding Its Impact on Business Dynamics

The Pharmaceutical Intermediates Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Pharmaceutical Intermediates Market are:

Pfizer Inc.
Sanofi
BASF SE
Lianhe Chemical Technology Co., Ltd
Dishman Carbogen Amcis Ltd

Disclaimer: The companies listed above are not ranked in any particular order.

pharmaceutical-intermediates-market-cagr

Get the Pharmaceutical Intermediates Market top key players overview

By Type

GMP
Non-GMP

By Application

Antibiotics
Antipyretic Analgesics
Vitamins
Others

By Distribution Channel

Distributor
Direct Sales

By Geography

North America
- US
- Canada
- Mexico
Europe
- Germany
- France
- Italy
- United Kingdom
- Spain
- Switzerland
- Belgium
- Greece
- Norway
- Portugal
- Sweden
- Czech Republic
- Croatia
- Ireland
- Denmark
- Netherland
- Russia
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM

Company Profiles

Pfizer, Inc
Dishman Group
Dextra Laboratories Limited
Sanofi Winthrop Industries S.A.
Vertellus Holdings LLC
BASF SE
Lianhetech
Codexis
Midas Pharma GmbH
Chiracon GmbH

Frequently Asked Questions

What is the cost of Pharmaceutical Intermediates?

The costs of the Pharmaceutical Intermediates are much higher, and they may cost US$ 5â€“50, or more, per kgs. The cost may also differ from product to product types.

What are Pharmaceutical Intermediates?

Pharmaceutical intermediates are the raw materials used to manufacture active pharmaceutical ingredients for the final drug formulation. Pharmaceutical intermediates are used in the production of bulk drugs as well as for research and development purpose by various pharm and biopharma companies. Pharmaceutical intermediates are formed at the time of process of production or synthesis of active pharmaceutical ingredients.

What are the driving factors for the Pharmaceutical Intermediates market across the globe?

Key factors that are driving the market are to rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities. However, high cost of drug manufacturing hinders the market growth.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the Pharmaceutical Intermediates Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Pharmaceutical Intermediates Market Report Snapshots

Our Top Trending Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

Yukihiko Adachi CEO, Deep Blue, LLC.

Reason to Buy

Informed Decision-Making
Understanding Market Dynamics
Competitive Analysis
Customer Insights
Market Forecasts
Risk Mitigation
Strategic Planning
Investment Justification
Identifying Emerging Markets
Enhancing Marketing Strategies
Boosting Operational Efficiency
Tracking Industry Innovations
Aligning with Regulatory Trends

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

Is there support available if I can’t access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.